Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00798642 · ClinicalTrials.gov registry record · NA

Ulcerative Colitis Relapse Prevention Trial, Hypnosis

A NA study of Ulcerative Colitis and Inflammatory Bowel Disease, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT00798642 is a NA study of Ulcerative Colitis and Inflammatory Bowel Disease that has completed, run by Northwestern University. The registered enrollment target is 55 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00798642, a NA study of Ulcerative Colitis and Inflammatory Bowel Disease, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

The UCRPT is a randomized controlled trial to determine if a type of hypnotherapy will maintain remission in patients affected by Ulcerative Colitis.

Interventions

  • BEHAVIORAL Hypnotherapy
  • BEHAVIORAL Standard care
  • BEHAVIORAL Mind Body Therapy

Study Locations (1)

Illinois

  • Northwestern University, Feinberg School of Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2007-07
Est. Completion 2012-06
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00798642

The ClinicalTrials.gov registry entry for NCT00798642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (97% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 3 interventions - of which Hypnotherapy is the first listed.

NCT00798642 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00798642 about?

NCT00798642 is a clinical study titled "Ulcerative Colitis Relapse Prevention Trial, Hypnosis". The UCRPT is a randomized controlled trial to determine if a type of hypnotherapy will maintain remission in patients affected by Ulcerative Colitis.

What is the current status of trial NCT00798642?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2007-07. Estimated completion is 2012-06.

What conditions does trial NCT00798642 study?

This clinical trial studies the following conditions: Ulcerative Colitis, Inflammatory Bowel Disease.

What interventions are being tested in trial NCT00798642?

The interventions under investigation include: Hypnotherapy (BEHAVIORAL), Standard care (BEHAVIORAL), Mind Body Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00798642?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00798642 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.